Pagliarini Raymond - Authors' Affiliations, Novartis Institutes for Biomedical Research;Koch Institute for Cancer Research, Massachusetts Institute of Technology;Departments of Bioengineering and Pharmacology;and Moores Cancer Center, University of California, San Diego

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 50 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract B168: Identification of STX-241, a CNS-penetrant and Mutant-Selective EGFR Inhibitor with Activity on Osimertinib-Resistant C797x Mutations

Raymond A Pagliarini,Benjamin C Milgram, Deanna R Borrelli,Erin O'Hearn, Michael R. Huff,Brendon Ladd,Natasja Brooijmans,Weixue Wang,Petr Kuzmic,Angel Guzman-Perez,Darrin D Stuart

Molecular Cancer Therapeuticsno. 12_Supplement (2023)

Cited0Views0Bibtex

Supplementary Methods, Figures 1-5 from PIK3CA Mutation Uncouples Tumor Growth and Cyclin D1 Regulation from MEK/ERK and Mutant KRAS Signaling

Ensar Halilovic,Qing-Bai She,Qing Ye,Raymond Pagliarini,William R. Sellers,David B. Solit,Neal Rosen

crossref（2023）

Cited0Views0Bibtex

Patient-derived Glioblastoma Cultures As a Tool for Small-Molecule Drug Discovery

Ling F Ye,Eduard Reznik,Joshua M Korn,Fallon Lin,Guizhi Yang,Kimberly Malesky,Hui Gao, Alice Loo,Raymond Pagliarini,Tom Mikkelsen,Donald C Lo,Ana C deCarvalho,Brent R Stockwell

OncoTarget（2020）

Cited12Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn